Skip to main content

Want a detailed portfolio tracker?

Palisade Bio (PALI) P/E (2022 - 2026)

Palisade Bio (PALI) P/E from Mar 31, 2022 to Jul 21, 2026. The TTM Palisade Bio (PALI) P/E is -11.11. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Palisade Bio (PALI)

YearP/EChange
2026-11.11-29.41%
2025-15.74+803.71%
2024-1.74-78.90%
2023-8.26-38.25%
2022-13.37N/A

Comparison Palisade Bio (PALI) P/E with competitors

Palisade Bio (PALI) P/E is -11.11.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.67%
FGENFibroGen Inc0.24-102.16%
CHRSCoherus Biosciences Inc0.85-107.64%
FBIOFortress Biotech Inc0.95-108.54%
ORMPOramed Pharmaceuticals Inc1.50-113.53%
AGENAgenus Inc3.01-127.08%
INVAInnoviva Inc3.15-128.38%
VXRTVaxart Inc3.55-131.94%
CRMDCorMedix Inc3.63-132.65%
CVACCureVac N.V.4.45-140.00%
GLPGGalapagos NV4.86-143.72%
SRPTSarepta Therapeutics Inc4.88-143.93%
ABEOAbeona Therapeutics Inc5.39-148.48%
ABUSArbutus Biopharma Corp5.60-150.35%
ZVRAZevra Therapeutics Inc5.89-152.98%
SPROSpero Therapeutics Inc6.23-156.05%
CGENCompugen Ltd6.31-156.82%
RIGLRigel Pharmaceuticals6.87-161.84%
SLXNSilexion Therapeutics Corp7.30-165.65%
OMEROmeros Corporation9.26-183.32%
AUPHAurinia Pharmaceuticals Inc9.58-186.25%
PLXProtalix BioTherapeutics Inc10.89-198.00%
ACADAcadia Pharmaceuticals Inc11.73-205.54%
TBPHTheravance Biopharma Inc12.26-210.34%
ADMAAdma Biologics Inc12.42-211.75%
HRMYHarmony Biosciences Holdings Inc13.82-224.36%
SABSSAB Biotherapeutics Inc14.14-227.21%
NAGENiagen Bioscience Inc14.82-233.34%
INCYIncyte Corp15.82-242.38%
REGNRegeneron Pharmaceuticals Inc15.86-242.69%
PBYIPuma Biotechnology Inc17.32-255.82%
CPRXCatalyst Pharmaceuticals Inc17.44-256.93%
EXELExelixis Inc17.54-257.82%
TGTXTG Therapeutics Inc18.97-270.67%
MDXGMimedx Group Inc20.55-284.94%
XOMAXOMA Royalty Corp22.87-305.85%
ARGXArgen X SE24.30-318.65%
CTMXCytomX Therapeutics Inc24.82-323.36%
XOMAOXOMA Royalty Corp25.34-328.07%
HALOHalozyme Therapeutics Inc25.62-330.58%
XOMAPXOMA Royalty Corp25.67-331.00%
VRTXVertex Pharmaceuticals Inc27.99-351.92%
RPRXRoyalty Pharma plc - Class A28.69-358.16%
SLNOSoleno Therapeutics Inc29.02-361.11%
ASNDAscendis Pharma A/S30.09-370.74%
LGNDLigand Pharmaceuticals Inc - Class B37.91-441.17%
APLSApellis Pharmaceuticals Inc39.02-451.15%
BMRNBiomarin Pharmaceutical Inc42.21-479.86%
KRYSKrystal Biotech Inc45.34-508.04%
ONCBeiGene Ltd69.54-725.79%
PHARPharming Group N.V.75.03-775.15%
TECHBio-Techne Corp101.96-1017.51%
VCELVericel Corp109.92-1089.17%
ALNYAlnylam Pharmaceuticals Inc117.96-1161.55%
GMABGenmab140.29-1362.46%
TLXTelix Pharmaceuticals Ltd162.15-1559.19%
CORTCorcept Therapeutics Inc212.86-2015.48%